pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Clinical significance of reactivity indicators of specific antibacterial immunity to antigens of duodenal content microbiota in various types of upper digestive tract inflammatory pathology

    Редактор | 2023, Original articles, Practical medicine part 21 №2. 2023 | 18 марта, 2023

    O.I. PIKUZA1, R.A. FAIZULLINA1, A.M. ZAKIROVA1, M.A. KAZAKOVA1, E.A. SAMORODNOVA1, M.F. SABIRZYANOVA2, O.I. LUKINA2

     1Kazan State Medical University, Kazan

    2Central City Clinical Hospital No. 18 named after Professor K.Sh. Zyyatdinov, Kazan

     Contact details:

    Zakirova A.M. — PhD (medicine), Associate Professor of the Department of Propaedeutics of Children’s Diseases and Faculty Pediatrics

    Address: 49B Butlerov St., Kazan, Russian Federation, 420012, tel.: +7 (843) 236-06-52, e-mail: azakirova@gmail.com

     The purpose was to study the reactivity of antibacterial immunity to pathogens of duodenal content microbiota in 94 school-age children with inflammatory lesions of the upper digestive tract (UDT).

    The research

    The obtained a significant role of specific antibacterial (AB) immunity to antigens of duodenal content microbiota in the course of inflammatory process in the upper gastrointestinal tract (UGIT). It was revealed that during the formation of the combined nature of the inflammatory process in the gastroduodenal zone and the biliary tract, functional changes in antiendotoxin protection are recorded. This is confirmed by a decrease in the concentration of antibodies to antigens of gram (-) pathogens against the background of a pronounced dysbiotic process in the digestive system. A clinical marker of this situation is a more severe course of the disease in this category of patients, often taking on a relapsing character.

    Conclusions. In a combination of chronic gastroduodenitis (CGD) and cholecystitis (CC), in contrast to the isolated course of CGD, a significant decrease in the concentration of antibodies to antigens of Escherichia coli, Klebsiella pneumonia, glycolipid (GLP) and an expansion of the spectrum of microorganisms in the duodenal content were revealed. The reactivity of specific humoral AB immunity to the bile microbiota reflects the severity of the clinical course of the inflammatory process in the UDT and determines the risk of a recurrent course.

    Key words: children, specific antibacterial immunity, chronic cholecystitis, chronic gastroduodenitis, microbiota.

    REFERENCES

    1. Morozova V.M., Galiakbarova E.A., Vasil’eva O.V. et al. Identification of risk factors for the development of gastroduodenal pathology in children at the hospital stage. Vestnik Bashkirskogo gos. med. un-ta, 2019, no. 1, pp. 506–510 (in Russ.), URL: http://s.siteapi.org/7bd21d3a35e453b.ru/docs/fcyiywonknk8ow844o8gw4w4osckgo
    2. Kazakova M.A., Pozdeev O.K., Valeeva Yu.V. et al. Species spectrum of the microflora of the mucous membrane of the upper digestive tract and its influence on the development of pathology in children. Kazanskiy meditsinskiy zhurnal, 2017, vol. 98, no. 4, pp. 557–563 (in Russ.). DOI: 10.17750/KMJ2017-557
    3. Pikuza O.I., Fayzullina R.A., Zakirova A.M. et al. Adhesion of Candida albicans on buccal epitheliocytes as an indicator of homeostatic balance of microbiota in children with chronic gastroduodenitis. Kazanskiy meditsinskiy zhurnal, 2022, vol. 103, no. 5, pp. 744–750 (in Russ.). DOI: 10.17816/KMJ2022-744
    4. Kazakova M.A. Features of microecological disorders of the organs of the gastroduodenal region and the hepatobiliary system in children. Vestnik sovremennoy klinicheskoy meditsiny, 2017, vol. 6, no. 6, pp. 15–20 (in Russ.). DOI: 10.20969/VSKM.2017.10(6).15-20
    5. Muhammad J.S., Sugiyama T., ZaidiS F. Gastric pathophysiological and outs of Helicobacterpylori: a review. J. Pak. Med. Assoc, 2013, vol. 63 (12), rr. 1528–1533. PMID: 24397100.
    6. Franceschi F., Zuccala G., Roccarina D. et al. Clinical effects of Helicobacter pylori outside the stomach. Nat. Rev. Gastroenterol. Hepatol, 2014, vol. 11 (4), rr. 234–242. DOI: 10.1038/nrgastro.2013.243
    7. Kandelaki S., Kordzaia D. Helicobacter and hepatobiliary diseases: conceptual view and review of the literature. Georgian Med. News, 2014, vol. 232–233, rr. 92–98. PMID: 25214281.
    8. Waluga M., Kukla M., Їorniak M. et al. From the stomach to other organs: Helicobacter pylori and the liver. World J. Hepatol, 2015, vol. 28; 7 (18), rr. 2136–2146. DOI: 10.4254/wjh.v7.i18.2136

    Метки: 2023, A.M. ZAKIROVA, Children, chronic cholecystitis, chronic gastroduodenitis, E.A. SAMORODNOVA, M.A. KAZAKOVA, M.F. SABIRZYANOVA, microbiota, O.I. LUKINA, O.I. PIKUZA, Practical medicine part 21 №2. 2023, R.A. FAIZULLINA, specific antibacterial immunity

    ‹ Relationship between angiotensin II level and the structural parameters of heart and prognosis in the post-infarction period Early diagnosis of inflammatory bowel diseases in patients with spondyloarthritis ›
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©